Marked disparity between age‐related changes in dopamine and other presynaptic dopaminergic markers in human striatum

Because age‐related changes in brain dopaminergic innervation are assumed to influence human disorders involving dopamine (DA), we measured the levels of several presynpatic DAergic markers [DA, homovanillic acid, tyrosine hydroxylase (TH), aromatic l‐amino acid decarboxylase (AADC), vesicular monoamine transporter 2 (VMAT2), and dopamine transporter (DAT)] in post‐mortem human striatum (caudate and putamen) from 56 neurologically normal subjects aged 1 day to 103 years. Striatal DA levels exhibited pronounced (2‐ to 3‐fold) post‐natal increases through adolescence and then decreases during aging. Similarly, TH and AADC increased almost 100% during the first 2 post‐natal years; however, the levels of TH and, to a lesser extent, AADC then declined to adult levels by approximately 30 years of age. Although VMAT2 and DAT levels closely paralleled those of TH, resulting in relatively constant TH to transporter ratios during development and aging, a modest but significant decline (13%) in DAT levels was observed in only caudate during aging. This biphasic post‐natal pattern of the presynaptic markers suggests that striatal DAergic innervation/neuropil appears to continue to develop well past birth but appears to become overelaborated and undergo regressive remodeling during adolescence. However, during adulthood, a striking discrepancy was observed between the loss of DA and the relative preservation of proteins involved in its biosynthesis and compartmentation. This suggests that declines in DA‐related function during adulthood and senescence may be explained by losses in DA per se as opposed to DAergic neuropil.

[1]  V. Tsang,et al.  Optimum dissociating condition for immunoaffinity and preferential isolation of antibodies with high specific activity. , 1991, Journal of immunological methods.

[2]  L. Cote,et al.  Biochemical changes in normal aging in human brain. , 1983, Advances in neurology.

[3]  E. Hirsch,et al.  New Species of Human Tyrosine Hydroxylase mRNA Are Produced in Variable Amounts in Adrenal Medulla and Are Overexpressed in Progressive Supranuclear Palsy , 1996, Journal of neurochemistry.

[4]  N. Volkow,et al.  Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging , 1998, Annals of neurology.

[5]  A. Levey,et al.  Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease , 1996, Neurology.

[6]  A. Levey,et al.  Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users , 1996, Annals of neurology.

[7]  I. Black,et al.  Postmortem changes in brain catecholamine enzymes. , 1975, Archives of neurology.

[8]  S. Kish,et al.  Influence of development and aging on brain biopterin , 1998, Neurology.

[9]  T. Bonner,et al.  Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Langston,et al.  Aging and the nigrostriatal dopamine system: a non-human primate study. , 1994, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[11]  P. Yates,et al.  The effects of ageing on the pigmented nerve cells of the human locus caeruleus and substantia nigra , 1979, Acta Neuropathologica.

[12]  R. Surtees,et al.  Aromatic L‐amino acid decarboxylase deficiency , 1992, Neurology.

[13]  L. Naudon,et al.  Reserpine or chronic paroxetine treatments do not modify the vesicular monoamine transporter 2 expression in serotonin-containing regions of the rat brain , 2000, Neuropharmacology.

[14]  S. Kish,et al.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.

[15]  O. Hornykiewicz,et al.  OCCURRENCE AND DISTRIBUTION OF AROMATIC l‐AMINO ACID (l‐DOPA) DECARBOXYLASE IN THE HUMAN BRAIN , 1972, Journal of neurochemistry.

[16]  S. Kish,et al.  Aging Produces a Specific Pattern of Striatal Dopamine Loss: Implications for the Etiology of Idiopathic Parkinson's Disease , 1992, Journal of neurochemistry.

[17]  M. Goldin,et al.  Regulation of rat brain vesicular monoamine transporter by chronic treatment with ovarian hormones , 1998 .

[18]  D. Rosenberg,et al.  Changes in the dopaminergic innervation of monkey prefrontal cortex during late postnatal development: A tyrosine hydroxylase immunohistochemical study , 1994, Biological Psychiatry.

[19]  J. Haycock,et al.  Striatal 3,4‐dihydroxyphenylalanine decarboxylase in aging: Disparity between postmortem and positron emission tomography studies? , 1995, Annals of neurology.

[20]  D. Rosenberg,et al.  Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: A tyrosine hydroxylase immunohistochemical analysis , 1995, The Journal of comparative neurology.

[21]  J Tauscher,et al.  Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  Y. Agid,et al.  Striatal dopamine deficiency in parkinson's disease: Role of aging , 1989, Annals of neurology.

[23]  R. Floyd Antioxidants, oxidative stress, and degenerative neurological disorders. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[24]  K. Frey,et al.  The vesicular monoamine transporter is not regulated by dopaminergic drug treatments. , 1995, European journal of pharmacology.

[25]  J. Kleinman,et al.  Decreased density of human striatal dopamine uptake sites with age. , 1986, European Journal of Pharmacology.

[26]  P. Mcgeer,et al.  Aging and extrapyramidal function. , 1977, Archives of neurology.

[27]  M. Caron,et al.  Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. , 1992, Molecular pharmacology.

[28]  K. Titani,et al.  Isolation and characterization of a cDNA clone encoding human aromatic L-amino acid decarboxylase. , 1989, Biochemical and biophysical research communications.

[29]  J. C. Stoof,et al.  [123I]β-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls , 1997, European Journal of Nuclear Medicine.

[30]  A. Rajput,et al.  Age, environments, and the number of substantia nigra neurons. , 1990, Advances in neurology.

[31]  D. Mash,et al.  High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. , 1994, The Journal of pharmacology and experimental therapeutics.

[32]  Kremzner Lt,et al.  Biochemical changes in normal aging in human brain. , 1983 .

[33]  G. Di Chiara The role of dopamine in drug abuse viewed from the perspective of its role in motivation. , 1995, Drug and alcohol dependence.

[34]  P. Seeman,et al.  Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. , 1975, Science.

[35]  V. Tennyson,et al.  The developing neostriatum of the rabbit: correlation of fluorescence histochemistry, electron microscopy, endogenous dopamine levels, and ( 3 H)dopamine uptake. , 1972, Brain research.

[36]  D. Sparks,et al.  Synaptic Neurochemistry of Human Striatum During Development: Changes in Sudden Infant Death Syndrome , 1993, Journal of neurochemistry.

[37]  J. Haycock,et al.  Elevated Tyrosine Hydroxylase in the Locus Coeruleus of Suicide Victims , 1994, Journal of neurochemistry.

[38]  J S Fowler,et al.  Decreased dopamine transporters with age in healthy human subjects , 1994, Annals of neurology.

[39]  P. Davies,et al.  REGIONAL DISTRIBUTION OF MONOAMINES AND THEIR METABOLITES IN THE HUMAN BRAIN , 1978, Journal of neurochemistry.

[40]  G. Chiara The role of dopamine in drug abuse viewed from the perspective of its role in motivation , 1995 .

[41]  J. Haycock Multiple Forms of Tyrosine Hydroxylase in Human Neuroblastoma Cells: Quantitation with Isoform‐Specific Antibodies , 1993, Journal of neurochemistry.

[42]  J. Haycock Four Forms of Tyrosine Hydroxylase Are Present in Human Adrenal Medulla , 1991, Journal of neurochemistry.

[43]  G. Gopinath,et al.  Developing substantia nigra in human: a qualitative study. , 1994, Developmental neuroscience.

[44]  R A Koeppe,et al.  Imaging the vesicular monoamine transporter. , 2001, Advances in neurology.

[45]  M. Wolf,et al.  Effect of Aging on Tyrosine Hydroxylase Protein Content and the Relative Number of Dopamine Nerve Terminals in Human Caudate , 1991, Journal of neurochemistry.

[46]  J. Haycock Quantitation of tyrosine hydroxylase, protein levels: spot immunolabeling with an affinity-purified antibody. , 1989, Analytical biochemistry.

[47]  J. Haycock,et al.  Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy , 1995, Movement disorders : official journal of the Movement Disorder Society.

[48]  P. Fitzpatrick,et al.  Tetrahydropterin-dependent amino acid hydroxylases. , 1999, Annual review of biochemistry.

[49]  H. Ehringer,et al.  Verteilung Von Noradrenalin Und Dopamin (3-Hydroxytyramin) Im Gehirn Des Menschen Und Ihr Verhalten Bei Erkrankungen Des Extrapyramidalen Systems , 2005, Klinische Wochenschrift.

[50]  S. Leff,et al.  Age‐related decreases in GTP‐cyclohydrolase‐I immunoreactive neurons in the monkey and human substantia nigra , 2000, The Journal of comparative neurology.

[51]  O. Hornykiewicz,et al.  Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. , 1960, Parkinsonism & related disorders.

[52]  L. Iversen,et al.  Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. , 1974, Brain : a journal of neurology.

[53]  Y. Agid,et al.  Preservation of midbrain catecholaminergic neurons in very old human subjects. , 2000, Brain : a journal of neurology.

[54]  H. Haug,et al.  Morphometry of the human cortex cerebri and corpus striatum during aging , 1991, Neurobiology of Aging.

[55]  P. Mcgeer,et al.  Age Changes in the Human for Some Enzymes Associated with Metabolism of Catecholamines, GABA and Acetylcholine , 1975 .

[56]  T. Sourkes,et al.  Monoamine metabolism in human brain. , 1977, Archives of General Psychiatry.

[57]  F. Carroll,et al.  Striatal [125I]RTI-55 binding sites in cocaine-abusing humans , 1998, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[58]  J. Marcusson,et al.  Age-correlated loss of dopamine uptake sites labeled with [3H]GBR-12935 in human putamen , 1989, Neurobiology of Aging.

[59]  A. Levey,et al.  Postnatal development of tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in monkey rostral entorhinal cortex. , 1998, Cerebral cortex.

[60]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[61]  S. Gilman,et al.  Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging , 1996, Annals of neurology.

[62]  P. Greengard,et al.  Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[63]  N. Volkow,et al.  Dopamine transporters decrease with age. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[64]  P. Mcgeer,et al.  Distribution of tyrosine hydroxylase activity in adult and developing brain. , 1967, Canadian journal of biochemistry.

[65]  M. Bannon,et al.  Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[66]  J. Haycock,et al.  Four isoforms of tyrosine hydroxylase are expressed in human brain , 1993, Neuroscience.

[67]  S. Leach,et al.  Elimination of nonspecific adsorption of serum proteins by Sepharose-bound antigens. , 1978, Analytical biochemistry.

[68]  Janet R. Saffer,et al.  Effects of age on dopamine transporters in healthy humans. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[69]  L. Iversen,et al.  Huntington's Chorea , 1974 .

[70]  G. Duncan,et al.  Cocaine use increases [3HWIN 35428 binding sites in human striatum , 1993, Brain Research.

[71]  Y. Yoshida,et al.  Alterations of tetrahydrobiopterin biosynthesis and pteridine levels in mouse tissues during growth and aging , 2000, Brain and Development.

[72]  W. Gibb,et al.  Dopa‐responsive dystonia: Pathological and biochemical observations in a case , 1994, Annals of neurology.

[73]  S J Kish,et al.  Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self- administration , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[74]  P. Gaspar,et al.  Regional Distribution of Neurotransmitter Synthesizing Enzymes in the Basal Ganglia of Human Brain , 1980, Journal of neurochemistry.

[75]  K. Y. Little,et al.  425. Cocaine effects on striatal dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) protein in humans , 2000, Biological Psychiatry.

[76]  INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .

[77]  J. Cano,et al.  Chronic inhibition of the high-affinity dopamine uptake system increases oxidative damage to proteins in the aged rat substantia nigra. , 1997, Free radical biology & medicine.

[78]  J. Haycock Species differences in the expression of multiple tyrosine hydroxylase protein isoforms , 2002, Journal of neurochemistry.

[79]  J. Haycock Polyvinylpyrrolidone as a blocking agent in immunochemical studies. , 1993, Analytical biochemistry.

[80]  S. Kish,et al.  The Vesicular Monoamine Transporter, in Contrast to the Dopamine Transporter, Is Not Altered by Chronic Cocaine Self-Administration in the Rat , 1996, The Journal of Neuroscience.

[81]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[82]  B. Winblad,et al.  Post-mortem distribution of dopamine and homo-vanillic acid in human brain, variations related to age, and a review of the literature , 2005, Journal of Neural Transmission.

[83]  P. Mcgeer,et al.  ENZYMES ASSOCIATED WITH THE METABOLISM OF CATECHOLAMINES, ACETYLCHOLINE AND GABA IN HUMAN CONTROLS AND PATIENTS WITH PARKINSON'S DISEASE AND HUNTINGTON'S CHOREA , 1976, Journal of neurochemistry.